Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.3M
5M shares
52-week range
$0.24 – $3.48
1% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
ADRC
Borrow rate
106.03%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $658.0K | $1.3M |
| Cost of revenue | $72.3K | $461.7K | $708.9K | $747.6K | $559.8K | $512.7K | $1.2M | $4.0M |
| Gross profit | $0 | $0 | −$708.9K | −$747.6K | −$559.8K | −$512.7K | −$580.0K | −$2.7M |
| Gross margin | — | — | — | — | — | — | -88.1% | -202.3% |
| R&D | $19.3M | $19.9M | $16.0M | $3.2M | $5.8M | $5.2M | $5.5M | $2.4M |
| Operating income | −$20.6M | −$22.7M | $2.3M | −$10.9M | −$11.1M | −$9.7M | −$8.6M | −$7.5M |
| EBITDA | −$20.5M | −$22.2M | $2.8M | −$10.4M | −$10.5M | −$9.2M | −$7.0M | −$6.5M |
| Net income | −$23.5M | −$31.6M | −$1.4M | −$8.2M | −$5.8M | −$6.5M | $4.8M | −$8.3M |
| Net margin | — | — | — | — | — | — | 728.9% | -633.6% |
| EPS (diluted) | -1435800.00 | -1548800.00 | -12.40 | -80.00 | -30.80 | -16.80 | 6.00 | -3.60 |
Annual figures · source: Financial Modeling Prep
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
www.scinai.comNo one on the platform currently holds SCNI.
No tracked institution reports a position in SCNI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-05-21 | 1-for-10reverse |
| 2022-11-25 | 1-for-10reverse |
No one on the platform has traded SCNI yet.
| $7M |
| — |
| ONCOOnconetix, Inc. | $0.95 | -2.27% | $318764 | — |
| PBMPsyence Biomedical Ltd. | $3.10 | +4.38% | $58959 | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$SCNI I’m just hear for the @Richard_Roma comments. Funny shit. Been dropping the bangors for years now hahahahahaha
View on StockTwits ↗$SCNI how can it be in the .20s... who issues shares to dump yhem in the .20s.. crazy. So no catalyst, i think we know whats next.
View on StockTwits ↗$SCNI what you mean is your hoping there is a bigger sucker to take this loss off your hands 💩
View on StockTwits ↗$SCNI "enhancing compensation"? This Israeli bioturd is only good at enriching executive compensation while failing shareholders This The agenda includes re-electing board members, increasing authorized ordinary shares, amending and enhancing compensation arrangements for CEO Amir Reichman and Chairman Mark Germain, and ratifying Ziv Haft of BDO as the company’s auditor, steps that underscore Scinai’s efforts to strengthen governance, secure additional share capacity, and align leadership incentives with long-term performance.
View on StockTwits ↗$SCNI re-elected three directors and approved an amendment to increase authorized shares at its annual meeting.
View on StockTwits ↗$COSM Not too late for $SCNI holders to Join a winning ticker COSM. They say its going to ONE DOLLAR after opening bell tommorow. I dont guess or gamble. Get in where you fit in and parachute out whenever you want $SPY Gap down coming
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.